Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heliox administration for acute severe COPD exacerbation
2008-008274-31Phase 2Completed
- Sponsor
- Thomayer University Hospital
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of heliox in chronic obstructive pulmonary disease (COPD), sponsored by Thomayer University Hospital. Primary endpoints: Improvement in lung function, Resolution of acute respiratory insufficiency and 1 more. Started Apr 2009; status: completed.
02
Drugs
heliox
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2008-008274-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008274-31.